Home/Uvax Bio/Matthijs Schoots
MS

Matthijs Schoots

Chief of Staff and Head of Strategic Planning

Uvax Bio

Therapeutic Areas

Uvax Bio Pipeline

DrugIndicationPhase
HIV-1 VaccineHIV-1 preventionPre-clinical
Undisclosed Asset 1Infectious DiseaseResearch
Undisclosed Asset 2Infectious DiseaseResearch
Undisclosed Asset 3Infectious DiseaseResearch